U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2003
176
Name Type Language
TOSITUMOMAB
INN   MART.   MI   VANDF   WHO-DD  
INN  
Official Name English
TOSITUMOMAB [MART.]
Common Name English
TOSITUMOMAB [VANDF]
Common Name English
BEXXAR COMPONENT TOSITUMOMAB
Common Name English
TOSITUMOMAB COMPONENT OF BEXXAR
Common Name English
Tositumomab [WHO-DD]
Common Name English
TOSITUMOMAB [MI]
Common Name English
tositumomab [INN]
Common Name English
IMMUNOGLOBULIN G2A, ANTI-(HUMAN CD20 (ANTIGEN)) (MOUSE MONOCLONAL CLONE B1R1 .GAMMA.2A-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL CLONE B1R1 .LAMBDA.X-CHAIN, DIMER
Systematic Name English
Classification Tree Code System Code
NDF-RT N0000175658
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
EU-Orphan Drug EU/3/03/137
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
NCI_THESAURUS C141215
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
LIVERTOX NBK548341
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
NDF-RT N0000175078
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
FDA ORPHAN DRUG 79493
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
NDF-RT N0000000205
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
WHO-ATC V10XA53
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
Code System Code Type Description
EVMPD
SUB21030
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
PRIMARY
CAS
208921-02-2
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
PRIMARY
ChEMBL
CHEMBL1201604
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
PRIMARY
INN
7827
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
PRIMARY
NCI_THESAURUS
C2543
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
PRIMARY
WIKIPEDIA
TOSITUMOMAB
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
PRIMARY
FDA UNII
0343IGH41U
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
PRIMARY
RXCUI
263010
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
PRIMARY RxNorm
IUPHAR
6781
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
PRIMARY
DRUG BANK
DB00081
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
PRIMARY
MERCK INDEX
m10983
Created by admin on Sat Dec 16 01:12:15 GMT 2023 , Edited by admin on Sat Dec 16 01:12:15 GMT 2023
PRIMARY Merck Index
ACTIVE MOIETY
TOSITUMOMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966